Israel’s Check-Cap Ltd. is looking to increase compliance with colorectal cancer screening recommendations with its ingestible, X-ray-based, gastrointestinal imaging device. The Check-Cap Imaging Capsule is designed to detect clinically significant polyps within the same range of accuracy as a standard colonoscopy, without a hospital visit or aggressive bowel preparation.

For the manufacturers of computer-aided detection products, 2009 was not a good year. For the industry as a whole, revenues dropped 10%, according to "US Markets for Computer-Aided Diagnostic Imaging Products," a report recently issued by the Medtech Insight division of Elsevier Business Intelligence. This was largely due to the economic recession, cost pressures faced by hospitals, and a subsequent squeeze on capital equipment-related products. But for the foreseeable future, the industry is expected to grow at a compound annual rate of 11.1% to reach an estimated $185.3 million by the years 2013.

Brief summaries of recent medtech market and industry developments. This month we cover new developments in the CRM industry, Barrx Medical's breakthrough on RF ablation for for Barrett's esophagus, and CMS' decision not to cover computed tomography colongraphy for colorectal cancer screening.

The discoveries of the platelet-inhibiting antibody, ReoPro, and PerioStat, a formulation of doxycycline, put SUNY-Stony Brook on the tech transfer map. It is now working with start-ups, too.